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Summary
LAB (linker for activation of B cells), also known as
NTAL (non-T cell activation linker), is a LAT (linker
for activation of T cells)-like adaptor protein that is
expressed in B, NK, and mast cells. Its role in lympho-
cytes has not been clearly demonstrated. Here, we
showed that aged LAB-deficient (Lat22/2) mice devel-
oped an autoimmune syndrome. Lat22/2 T cells were
hyperactivated and produced more cytokines than
Lat2+/+ T cells. Even though LAB was absent in naive
T cells, LAB could be detected in activated Lat2+/+ T
cells. LAT-mediated signaling events were enhanced
in Lat22/2 T cells; however, they were suppressed in
T cells that overexpressed LAB. Mice with the Lat2
gene conditionally deleted from T cells also developed
the autoimmune syndrome like Lat22/2 mice. To-
gether, these data demonstrated an important role of
LAB in limiting autoimmune response and exposed
a mechanism regulating T cell activation.
Introduction
In recent years, a number of adaptor proteins have been
described to play an important role in regulation of T cell
activation (Horejsi et al., 2004; Jordan et al., 2003; Sa-
melson, 2002; Yablonski and Weiss, 2001). While some
adaptors, such as LAT (linker for activation of T cells)
and SLP-76 (the SH2 domain-containing leukocyte
protein), have a positive and essential role in the T cell
receptor (TCR)-mediated signaling and thymocyte de-
velopment (Clements et al., 1998; Finco et al., 1998;
Pivniouk et al., 1998; Yablonski et al., 1998; Zhang
et al., 1998, 1999), other adaptor proteins can negatively
regulate T cell activation. These negative or inhibitory
adaptor molecules include membrane-associated adap-
tors, such as SIT (SH2-interacting transmembrane adap-
tor protein) and LAX (linker for activation of X cells)
(Marie-Cardine et al., 1999; Zhu et al., 2002), and cyto-
plasmic adaptors, like Cbl (Casitas B-lineage lymphoma)
and SAP (SLAM-associated protein) (Joazeiro et al.,
1999; Naramura et al., 2002; Veillette, 2004). Mice defi-
cient in some of these negative adaptors develop spon-
taneous autoimmune diseases, indicating that these
proteins are critical in maintaining T cell tolerance or
homeostasis.
*Correspondence: zhang033@mc.duke.eduLAB (linker of activation of B cells), also known as
NTAL (non-T cell activation linker), is an adaptor protein
that is expressed in B cells, mast cells, and NK cells, but
not in naive T cells (Brdicka et al., 2002; Janssen et al.,
2003). Similar to LAT, it has multiple tyrosine residues
in its cytoplasmic tail, five of which are within a Grb2
binding motif (YxN). LAB also has a palmitoylation motif
and is localized to lipid rafts. Previous studies have
clearly demonstrated that LAT is an essential adaptor
protein in T cell activation and development. It functions
in TCR-mediated MAPK (mitogen-activated protein ki-
nase) activation and calcium flux by binding Grb2,
Gads (Grb2-related adaptor downstream of Shc), phos-
pholipase C (PLC)-g1, and other signaling molecules
upon phosphorylation by ZAP-70 (z-associated pro-
tein-70) tyrosine kinase (Finco et al., 1998; Liu et al.,
1999; Zhang et al., 1998, 2000). Recent studies indicate
that LAT binding to PLC-g1 is critical for LAT function in
T cell homeostasis (Aguado et al., 2002; Sommers et al.,
2002). Mice expressing LAT with a mutation at the PLC-
g1 binding site (Tyr136) develop a severe autoimmune
disease resulting from uncontrolled expansion of CD4+
T cells, a consequence of both defective negative selec-
tion and lack of T regulatory cells in these mice (Koon-
paew et al., 2006; Sommers et al., 2005). Although LAB
is similar to LAT and is capable of replacing LAT in thy-
mocyte development (Janssen et al., 2003), LAB does
not have the PLC-g1 binding site and fails to bind
PLC-g1 (Brdicka et al., 2002; Janssen et al., 2003).
Transgenic mice expressing LAB in Lat2/2 T cells
develop a Th2 type autoimmune disease similar to the
LatY136F knockin mice (Janssen et al., 2004), suggesting
that LAB functionally resembles the LATY136F mutant.
Upon B cell receptor (BCR) engagement, LAB is phos-
phorylated and interacts with Grb2. Studies with Grb2-
deficient and LAB-deficient DT40 chicken B cells sug-
gest that the Grb2-LAB complex positively regulates
BCR-mediated calcium signaling by switching off un-
identified inhibitory elements (Stork et al., 2004). How-
ever, deletion of the gene encoding LAB, recently re-
named Lat2, in mice has no substantial effect on B cell
development or BCR-mediated signaling (Wang et al.,
2005; Zhu et al., 2004). Thus, whether LAB functions
in the BCR pathway remains to be determined. LAB is
also expressed in bone marrow-derived mast cells.
Upon engagement of the high-affinity IgE receptor
(Fc3RI), LAB is also phosphorylated and associates
with Grb2. Mast cells deficient in LAB are hyperrespon-
sive in response to stimulation via the Fc3RI. Fc3RI-
mediated Erk (extracellular-regulated kinase) activation,
calcium flux, degranulation, and cytokine production are
enhanced in LAB-deficient (Lat22/2) mast cells, indicat-
ing that LAB negatively regulates mast cell function. LAB
also plays a positive role in mast cells. Mast cells defi-
cient in both the Lat and Lat2 genes have a further
reduction in Fc3RI-mediated signaling and mast cell
function in comparison with Lat2/2 mast cells (Volna
et al., 2004; Zhu et al., 2004).
Here, we report that aged LAB-deficient (Lat22/2)
mice developed a spontaneous autoimmune syndrome,
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758Figure 1. Development of an Autoimmune Syndrome in Aged Lat22/2 Mice
(A) The presence of DNA antibodies in aged Lat22/2mice. Sera from 10 6-month-old Lat22/2 and Lat2+/+ female mice were assayed for the con-
centrations of IgG specific to dsDNA by ELISA.
(B) Anti-nuclear antibody assay. Diluted sera from Lat22/2 and Lat2+/+ mice were used to stain slides with fixed HEp-2 cells. The presence of anti-
nuclear antibodies was revealed by FITC-conjugated goat anti-mouse IgG. A representative staining with the sera from three Lat22/2 mice and
one Lat2+/+ mouse is shown.
(C) Immune complex deposition in the glomeruli of Lat22/2mice. Cryosections of kidneys from three Lat22/2 and three Lat2+/+ mice were stained
with FITC-conjugated goat anti-mouse IgG and visualized by fluorescence microscopy.
(D) Expression of Foxp3 in thymocytes and lymph node cells from Lat22/2 and Lat2+/+ mice. Numbers in the FACS plot indicate the percentages
of cells in quadrants or gated circles.evidenced by enlarged spleens and production of auto-
antibodies. T cells in these mice were hyperactivated
and hyperresponsive to anti-CD3 stimulation. They pro-
duced higher amounts of cytokines than T cells from
Lat2+/+ mice. Although LAB was not expressed in naive
T cells, it was upregulated in Lat2+/+ T cells after activa-
tion via the TCR. TCR-mediated signaling was enhanced
in Lat22/2 T cells. By using mice in which the Lat2 gene
can be deleted upon expression of the Cre recombi-
nase, we showed that the autoimmune syndrome was
caused by abnormal T cells. Our data indicated that
LAB negatively regulates T cell activation.
Results
Development of an Autoimmune Syndrome
in Aged Lat22/2 Mice
Analyses of cells from the bone marrow, thymus, spleen,
and lymph nodes by fluorescence-activated cell sorting
(FACS) revealed normal development of T and B lympho-
cytes in LAB-deficient (Lat22/2) mice. 5- to 8-week-old
Lat22/2 mice have no apparent abnormality. The sizes
of the spleen, thymus, and lymph nodes from Lat22/2
mice were similar to those from Lat2+/+ mice. However,
when old Lat22/2 mice and age-matched Lat2+/+ mice
(>6 months old) were analyzed, we found that spleensfrom Lat22/2mice were enlarged (data not shown). Total
numbers of splenocytes for Lat22/2 and Lat2+/+ mice are
(9.56 2.0)3 107 and (4.46 0.6)3 107, respectively. The
percentages of CD4+, CD8+, and B220+ cells were similar
in these mice: 17.7%6 2.3%, 8.3%6 1.4%, and 58.0%6
9.5%, respectively, in Lat22/2 mice and 18.5% 6 2.5%,
9.2%6 1.3%, and 63.0%6 3.4% in Lat2+/+ mice.
Because of the apparent splenomegaly in aged
Lat22/2mice, we further looked for signs of autoimmune
diseases. We first examined whether these mice pro-
duced autoantibodies against double-stranded DNA
(dsDNA). The concentrations of serum IgG specific for
dsDNA were measured by ELISA. At 6 months of age,
the concentrations of autoantibodies in Lat22/2 mice
were substantially higher than in Lat2+/+ mice (Figure 1A)
and were elevated even more in 1-year-old Lat22/2mice
(data not shown). We further confirmed the presence of
autoantibodies by performing an anti-nuclear antibody
(ANA) assay. Sera from 6-month-old Lat22/2 and Lat2+/+
mice were used to stain fixed HEp-2 cells by immunoflu-
orescence microscopy. As shown in Figure 1B, only sera
from Lat22/2 mice gave clearly positive fluorescence
signals. Staining patterns with sera from three Lat22/2
mice varied. While some clearly showed nuclear stain-
ing, others revealed homogeneous staining positive in
both the nucleus and cytoplasm. To determine whether
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with immune complex deposition in the glomeruli of
Lat22/2mice, cryosections of kidneys were stained with
fluorescein isothiocyanate (FITC)-conjugated goat anti-
mouse IgG and examined by fluorescence microscopy.
A strong fluorescence signal was clearly detected in
the glomeruli of Lat22/2mice, whereas only background
immunofluorescence was seen in the glomeruli ofLat2+/+
mice (Figure 1C). Together, these data indicated that
aged Lat22/2 mice develop a spontaneous autoimmune
syndrome.
To investigate the cause for autoimmunity in aged
Lat22/2 mice, we investigated whether T regulatory
(Treg) cell development is normal. Treg cells play an im-
portant role in suppressing autoreactive T cells (Sakagu-
chi, 2004; Shevach et al., 2001). They are CD4+CD25+
and express Foxp3, a transcription factor involved in
development of Treg cells (Fontenot et al., 2003). We ex-
amined expression of Foxp3 in thymocytes and spleno-
cytes from Lat2+/+ and Lat22/2 mice by intracellular
staining with a Foxp3 antibody followed by flow cytom-
etry analysis. Similar percentages of Foxp3+ cells were
seen in these mice (Figure 1D). In addition, Lat2+/+ and
Lat22/2 Treg cells showed a similar suppression of pro-
liferation of CD4+CD252 cells in vitro (data not shown).
These data suggested that the autoimmunity in aged
Lat22/2 mice was not due to abnormal Treg cell devel-
opment or function.
Hyperactivated T Cells in Aged Lat22/2 Mice
We then examined the activation status of B and T cells
in these mice by analyzing expression of activation
markers, CD86, CD80, and MHC class II (I-Ab) for B cells,
and CD25, CD69, CD44, CD62L, and CD45RB for T cells.
In 6-week-old mice, we did not observe substantial
differences in expression of these surface markers on
B or T cells from Lat22/2 and Lat2+/+ mice (data not
shown). In contrast, in 6-month-old mice, CD4+ T cells
from Lat22/2 mice showed increased expression of
CD25, CD69, and CD44 and decreased expression of
CD62L and CD45RB in comparison with those from
Lat2+/+ mice (Figure 2A). Similar differences in expres-
sion of these surface markers were also seen in CD8+ T
cells (data not shown). However, B cells from Lat22/2
mice had similar amounts of CD86, CD80, and MHC class
II as those from Lat2+/+ mice (data not shown). These
data indicated that there were more activated or memory
T cells in aged LAB-deficient mice.
Next, we performed intracellular staining to examine
whether Lat22/2 T cells produced more cytokines than
Lat2+/+ T cells. Splenocytes from aged Lat22/2 and
Lat2+/+ mice were stimulated by PMA (phorbol myristate
acetate) and ionomycin for 1 hr. After addition of Golgi-
stop, these cells were further stimulated for 3 hr. Cells
were then stained with anti-CD4 and CD8, fixed, perme-
ablized, and stained again with antibodies against differ-
ent cytokines. T cells from 5- to 6-week-old Lat22/2 and
Lat2+/+ mice produced very little IL (interleukin)-2, IL-4,
IL-10, and IFN (interferon)-g (data not shown). However,
T cells from 6-month-old Lat22/2 mice produced more
IL-2, IL-10, and IFN-g compared with T cells from age-
matched Lat2+/+ mice (Figure 2B), whereas similar per-
centages of IL-4-producing T cells were detected (data
not shown).We further examined proliferation of B and T cells in
response to stimulation via the antigen receptors. B
and T cells were purified from splenocytes from aged
Lat22/2 and Lat2+/+ mice via autoMACS (automatic
magnetic cell sorting) and were then stimulated with dif-
ferent concentrations of anti-IgM or anti-CD33, respec-
tively. Anti-IgM-induced [3H]thymidine incorporation
was similar between Lat22/2 and Lat2+/+ B cells (data
not shown); however, thymidine incorporation into T
cells from aged Lat22/2 mice was enhanced when low
concentrations of anti-CD3 (0.05 and 0.5 mg/ml) were
used (Figure 2C). The enhanced thymidine uptake could
be due to accelerated proliferation or decreased cell
death. To distinguish between these two possibilities,
T cells were labeled with CFSE (carboxy fluorescein
diacetate succinimide ester) before being stimulated
with different concentrations of anti-CD3. CFSE inten-
sity should be diluted after each cell division. As shown
in Figure 2D, Lat22/2 T cells divided faster than Lat2+/+
cells when 0.05 mg/ml anti-CD3 was used. We also as-
sayed anti-CD3-induced cell death by staining T cells
with Annexin V. No apparent differences were seen be-
tween Lat22/2 and Lat2+/+ T cells. These data indicated
that T cells in aged Lat22/2 mice were hyperresponsive
to stimulation via the TCR.
Expression of LAB in Activated T Cells
Results from Figure 2 indicated that T cells from aged
Lat22/2 mice were hyperactivated and produced more
cytokines. This result was not expected because previ-
ously published data showed that LAB is not expressed
in naive T cells (Brdicka et al., 2002; Janssen et al., 2003).
Thus, we hypothesized that while naive T cells do not ex-
press or express a trace amount of LAB, activated T
cells might upregulate LAB. To examine LAB expression
in T cells, naive CD4+ and CD8+ cells from Lat2+/+ mice
were purified by MACS. For activated T cells, spleno-
cytes from Lat2+/+ mice were stimulated in anti-CD3-
coated plates for 2 days and cultured in IL-2 media for
an additional 2–3 days before purification by MACS.
Real-time PCR was performed with cDNAs prepared
from these cells. The amount of LAB RNA was normal-
ized relative to b-actin. As shown in Figure 3A, LAB ex-
pression was indeed low in naive CD4+ and CD8+ T cells;
however, the amount of LAB RNA was increased by
w17-fold in CD4+ andw35-fold in CD8+ T cells activated
in vitro via CD3 in the presence of IL-2.
Because T cells from aged Lat22/2 mice were hyper-
activated, it is possible that in aged T cells, LAB is upre-
gulated to suppress T cell activation. To examine this
possibility, CD4+ and CD8+ T cells from 1-month-old
and 8-month-old mice were purified by FACS sorting.
B cells were also sorted from these mice as a control.
cDNAs were prepared from these cells and were then
used in real-time PCR. As seen in Figure 3B, the LAB
RNA was increased by approximately 5-fold in T cells
from 8-month-old mice while it was not changed sub-
stantially in B cells. We further purified memory
(CD4+CD62L2CD252), activated (CD4+CD62L2CD25+),
and naive (CD4+CD62L+) T cells from 8-month-old
mice and quantitated the amount of LAB RNA by real-
time PCR. The amount of LAB transcript in memory
and activated T cells was w6 and 8.5 times higher, re-
spectively, than in naive T cells (Figure 3C).
Immunity
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(A) Splenocytes from 6-month-old Lat22/2 and Lat2+/+ mice were stained with anti-CD4, CD8, and different T cell activation markers as indicated
in the figure. The shadowed histogram represents CD4+ T cells from Lat2+/+ mice, and the dark-lined histogram represents CD4+ T cells from
Lat22/2 mice. The figure shown is a representative of five mice for each genotype. Numbers indicate the percentages of gated Lat22/2 (top)
and Lat2+/+ (bottom) cells.
(B) Cytokine production in CD4+ T cells from 6-month-old Lat22/2 and Lat2+/+ mice. Splenocytes from 6-month-old Lat22/2 and Lat2+/+ mice
were analyzed by staining with anti-CD4 and CD8 followed by intracellular staining with antibodies against IFN-g, IL-10, and IL-2. The shadowed
histogram represents Lat2+/+ T cells. The dark-lined histogram represents Lat22/2 T cells. Numbers indicate the percentages of cytokine-
producing Lat22/2 (top) and Lat2+/+ (bottom) cells. The figure shown represents three independent experiments.
(C) Thymidine incorporation. Purified T cells from Lat22/2 and Lat2+/+ mice were stimulated with 0, 0.05, 0.5, and 5 mg/ml anti-CD3 in the presence
of anti-CD28 (0.5 mg/ml) for 24 hr before assayed for [3H]thymidine incorporation. The figure shown is representative of three independent
experiments performed in triplicate. Bars indicate mean 6 SD.
(D) Increased proliferation of T cells from aged Lat22/2 mice. CFSE-labeled T cells from Lat22/2 and Lat2+/+ mice were stimulated with 0, 0.05,
0.5, and 5 mg/ml anti-CD3 in the presence of anti-CD28 (0.5 mg/ml) for 48 hr before being analyzed by FACS. The thin-lined histogram represents
cells without anti-CD3 stimulation. The figure shown is representative of three independent experiments.We next determined whether the amount of LAB pro-
tein in those cells correlated with the abundance of LAB
RNA. Naive T cells and T cells activated in vitro were
lysed, and postnuclear lysates were subjected to immu-
noprecipitation with anti-LAB. We also immunoprecipi-
tated LAB from B cells as a positive control. Lysates
from corresponding cell populations from Lat22/2
mice were used as negative controls. Immunoprecipi-
tates were analyzed by an anti-LAB immunoblot. As
shown in Figure 3D, LAB protein could be clearly de-
tected in activated CD4+ and CD8+ cells.
We further examined whether LAB could be phos-
phorylated upon stimulation via the TCR. CD4+ andCD8+ T cells were activated in vitro and were restimu-
lated with anti-CD3 and anti-CD4 or anti-CD3 and anti-
CD8, respectively, before lysis. LAB was immunoprecip-
itated from cell lysates and analyzed by immunoblotting
with anti-pTyr and anti-LAB. As shown in Figure 3E, LAB
was clearly phosphorylated after TCR engagement.
Taken together, these data indicated that LAB protein
was indeed expressed in activated T cells.
Enhanced TCR-Mediated Signaling in Lat22/2 T Cells
Since LAB was expressed in activated T cells and could
be phosphorylated upon stimulation via the TCR,
we next examined whether LAB deficiency affected
LAB in T Cell Signaling
761Figure 3. Expression of LAB in Activated T Cells
(A) Real-time PCR to detect LAB expression in T cells. Cells were sorted from spleens directly or after activation in vitro with a CD33 antibody. The
amount of LAB RNA in each population was normalized by the b-actin RNA. The figure shown in (A)–(C) is representative of three independent
experiments performed in triplicate. Bars indicate mean 6 SD.
(B) CD4+, CD8+, and B220+ cells were sorted by FACS from 1-month-old and 8-month-old mice and used in real-time PCR.
(C) Naive (CD4+CD62L+), memory (CD4+CD62L2CD252), and activated (CD4+CD62L2CD25+) T cells were sorted from 11-month-old mice and
used in real-time PCR.
(D) LAB protein in activated T cells. Activated T cells were purified as in (A). B cells were isolated directly from spleens by MACS. Cells were lysed
in RIPA buffer and lysates were immunoprecipitated with anti-LAB serum followed by immunoblotting with a LAB monoclonal antibody. Cells
from Lat22/2 mice were used as negative controls.
(E) Phosphorylation of LAB in activated T cells. Activated CD4+ or CD8+ T cells from Lat22/2 and Lat2+/+ mice were rested and restimulated by
crosslinking CD3 and CD4 or CD3 and CD8 for 1.5 min before lysis in RIPA buffer. Lysates were immunoprecipitated with anti-LAB sera and
analyzed by immunoblotting with either a pTyr or LAB antibody. The figure shown is representative of three independent experiments.TCR-mediated signaling in activated T cells. Spleno-
cytes from Lat22/2, Lat2+/+, and Lat2Tg mice were acti-
vated with anti-CD3 and were expanded in IL-2 medium
for 3 days. In T cells from Lat2Tg mice, LAB was overex-
pressed under control of the human CD2 promoter in
Lat+/+ T cells (Janssen et al., 2004). Since most of the
T cells under this culture condition were CD8+ T cells,
only CD8+ T cells were purified and used in analysis of
TCR-mediated signaling. First we examined overall tyro-
sine phosphorylation of proteins after stimulation via the
TCR for 0, 1.5, 5, and 10 min. Total lysates were analyzed
by anti-pTyr immunoblotting. As seen in Figure 4A, the
most obvious difference in tyrosine phosphorylation of
proteins in T cells from different mice was LAT phos-
phorylation. Compared with Lat2+/+ T cells, Lat22/2 T
cells had increased LAT phosphorylation. In contrast,
Lat2Tg T cells had dramatically reduced LAT phosphor-
ylation. The effect of LAB expression on LAT phosphor-
ylation was further confirmed by immunoblotting with an
antibody against LAT phosphorylated at pY191 (Figures
4B and 4C).
Two signaling events downstream of LAT phosphory-
lation are phosphorylation of PLC-g1 and activation
of Erk. Correlated with LAT phosphorylation, PLC-g1phosphorylation and Erk activation was slightly in-
creased in Lat22/2 T cells, but reduced in Lat2Tg T cells.
In addition, phosphorylation of Akt (protein kinase B), an
important protein in the PI3K pathway, was also en-
hanced in Lat22/2 cells, while it was suppressed in
Lat2Tg cells (Figures 4B and 4C). We examined TCR-
mediated phosphorylation of ZAP-70 tyrosine kinase
and c-Cbl, a protein that negatively regulates T cell acti-
vation. Cbl phosphorylation was similar in these cells.
Phosphorylation of ZAP-70 was also similar in Lat22/2
T cells; however, it was slightly reduced in Lat2Tg T cells
(Figures 4B and 4C). We also examined TCR-mediated
Ca2+ flux, a consequence of PLC-g1 activation, by
crosslinking CD3 and CD4 or CD3 and CD8. Calcium
flux in activated Lat22/2 CD4+ and CD8+ T cells was
enhanced. In contrast, it was reduced in Lat2Tg T cells
(Figure 4D). These data suggested that LAB likely func-
tions to inhibit LAT phosphorylation and LAT-mediated
signaling events in T cells.
LAT Raft Localization, Cytokine Production,
and Proliferation
Our previous data indicate that LAT and LAB may com-
pete for localization to lipid rafts in mast cells. To
Immunity
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(A and B) Tyrosine phosphorylation of proteins. Activated CD8+ T cells were restimulated with anti-CD3 (5 mg/ml) and anti-CD8 (1 mg/ml) for in-
dicated time points (minutes) before lysis in RIPA buffer. Cell lysates were analyzed by immunoblotting with anti-pTyr, phospho-specific, or pan
antibodies against LAT, PLC-g1, Erk, and Akt. Phosphorylation of ZAP-70 and Cbl was assayed by immunoprecipitation followed by immuno-
blotting with anti-pTyr. Each band was quantified, and the relative intensities of the phosphorylated form after normalization to the total amount
of each protein were shown. Data shown are from one representative of three experiments.
(C) Quantitative analysis of changes in protein phosphorylation. Relative intensities of the phosphorylated form of each protein at 1.5 min after
activation of Lat22/2 or Lat2Tg T cells were normalized to those in Lat2+/+ T cells. Data from three independent experiments were used in calcu-
lation. The figure shows mean relative intensity of each protein from three independent experiments. Bars indicate mean 6 SD.
(D) Ca2+ mobilization. Activated CD4+ or CD8+ T cells were loaded with Indo-1. Ca2+ flux was induced by anti-CD3 (5 mg/ml) and CD4 (1 mg/ml) or
CD8 (1 mg/ml) crosslinking. Data shown are from one representative of three experiments.examine whether LAB also affects LAT localization to
rafts in T cells, we isolated proteins in lipid rafts and non-
raft fractions from activated Lat22/2, Lat2+/+, and Lat2Tg
T cells by sucrose gradient ultracentrifugation. After
centrifugation, each fraction was analyzed by immuno-
blotting with a LAT antibody. As shown in Figure 5A,
in activated T cells from Lat22/2, Lat2+/+, and Lat2Tg
mice, LAT was present in both raft (fractions 3–5) and
nonraft (fractions 7–12) fractions; however, the relative
amount of LAT in raft and nonraft fractions varied be-
tween cells tested. Compared with Lat2+/+ T cells,
Lat22/2 T cells had more LAT protein in raft fractions
and less in nonraft fractions. In contrast, Lat2Tg T cells
had less LAT in raft fractions and more in nonraft frac-
tions. These results suggested that in T cells, LAT and
LAB might compete for raft localization or palmitoyla-
tion. In the absence of LAB, more LAT protein moved
to lipid rafts, leading to increased tyrosine phosphoryla-
tion of LAT and enhanced LAT-mediated signaling.
We also assayed cytokine production in activated
Lat2+/+, Lat22/2, and Lat2Tg T cells. Since most of the ac-
tivated T cells under our culture condition were CD8+ Tcells, we purified these activated CD8+ Lat22/2, Lat2+/+,
and Lat2Tg T cells by MACS and quantitated cytokines
secreted by these T cells after restimulation with anti-
CD3 and anti-CD28 or PMA and ionomycin for 4 hr via
a multiplex cytokine assay. As shown in Figure 5B, com-
pared with Lat2+/+ T cells, Lat22/2T cells produced more
IL-2, IL-10, TNFa, IL-12, and IFN-g upon stimulation with
anti-CD3 and anti-CD28, while they produced a similar or
lower amount of cytokines when stimulated with PMA
and ionomycin. In contrast, Lat2Tg T cells produced
very little of these cytokines, especially when they were
stimulated with anti-CD3 and anti-CD28.
We further examined whether TCR-mediated prolifer-
ation of activated Lat22/2 T cells activated in vitro was
also enhanced like Lat22/2 T cells from aged mice. Acti-
vated T cells from Lat2+/+, Lat22/2, and Lat2Tg mice were
stimulated with different concentrations of anti-CD3 and
0.5 mg/ml anti-CD28. Proliferation of these T cells was
assayed by [3H]thymidine incorporation. As shown in
Figure 5C, compared with Lat2+/+ T cells, Lat22/2 T cells
were hyperresponsive to anti-CD3 stimulation while
Lat2Tg T cells were hyporesponsive. Together, these
LAB in T Cell Signaling
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(A) Localization of LAT in lipid rafts in activated CD8 T cells from Lat22/2, Lat2+/+, and Lat2Tg mice. Activated CD8+ T cells were lysed in 1% Triton
before ultracentrifugation on a sucrose gradient. 12 fractions were collected starting from the top of the sucrose gradient. Each fraction was
resolved on SDS-PAGE and blotted with a LAT antibody.
(B) Cytokine production. T cells from Lat22/2, Lat2+/+, and Lat2Tg mice were activated as in Figure 4. CD8+ T cells were purified, rested, and
restimulated with anti-CD3 (5 mg/ml) and CD28 (0.5 mg/ml), PMA+ionomycin, or left untreated. Cytokines secreted into the tissue culture super-
natants were quantitated with a multiplex cytokine kit.
(C) T cell proliferation. Activated CD8+ T cells were stimulated with different concentrations of anti-CD3 antibodies in the presence of anti-CD28
(0.5 mg/ml) for 24 hr followed by a 6 hr pulse with [3H]thymidine. Incorporation of [3H]thymidine was measured with a liquid scintillation counter.
The figure shown is representative of three independent experiments performed in triplicate. Bars indicate mean 6 SD.data indicated that LAB in T cells inhibited TCR-
mediated signaling, cytokine production, and T cell
proliferation.
Aggravation of the Autoimmune Disease in LatY136F
Mice by LAB Deficiency
Since our results suggested that LAB plays a negative
role in regulating T cell activation, we further investi-
gated the role of LAB in vivo via an autoimmune mouse
model, the LatY136F knockin mouse (Aguado et al., 2002;
Sommers et al., 2002), to see whether deletion of the
Lat2 gene leads to aggravation or lessening of the dis-
ease. In the LatY136F mice, a critical tyrosine of LAT
(Y136) responsible for binding PLC-g1 is mutated to
phenylalanine. This mutation leads to development of a
severe autoimmune disease with enormous expansion of
CD4+ T cells, splenomegaly, and production of autoanti-
bodies. We crossed Lat22/2 mice with the LatY136F mice
to generate Lat22/2Latm/m mice (m = Y136F). 11-week-
old Lat22/2Latm/m mice, together with age-matched
Lat2+/+, Lat22/2, and Latm/m mice, were examined. Lat2+/+
and Lat22/2 mice had similar sizes of spleen and lymph
nodes at this age. Latm/m mice had enlarged spleen
and lymph nodes, as previously reported. Comparedwith these mice, Lat22/2Latm/m mice had much bigger
spleens and lymph nodes (data not shown). Total num-
bers of splenocytes from these mice are: Lat22/2Latm/m,
(3.6 6 0.2) 3 108; Latm/m, (2.0 6 0.2) 3 108; Lat22/2, (2.9 6
0.1) 3 107; Lat2+/+, (2.7 6 0.2) 3 107. FACS analysis of
splenocytes showed that w44% splenocytes were
CD4+ in Latm/m mice resulting from uncontrolled expan-
sion of CD4+ T cells. However, in Lat22/2Latm/m mice,
there was even more expansion of CD4+ T cells and
w68% of splenocytes were CD4+ (Figure 6A). In addi-
tion, Lat22/2Latm/m mice had high titers of dsDNA anti-
bodies in their sera starting at as early as 6 weeks old,
while Latm/m mice started to have dsDNA antibodies at
10 weeks old. The autoantibody titers in Lat22/2Latm/m
mice were also higher than in Latm/m mice (Figure 6B).
Although there were differences in autoantibody pro-
duction, IgE and IgG1 concentrations were elevated
similarly in Lat22/2Latm/m and Latm/m mice (data not
shown) as previously reported (Wang et al., 2005), sug-
gesting that there is a dissociation between hypergam-
maglobulinemia and the presence of autoantibodies.
Our data indicated that the autoimmune phenotype in
Latm/m mice was aggravated by LAB deficiency and
suggested a negative role of LAB in T cells.
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(A) FACS analysis of CD4, CD8, and B220 on splenocytes from 11-week-old Lat22/2Latm/m (m = Y136F), Latm/m, Lat22/2, and Lat2+/+ mice. Num-
bers indicate the percentages of cells in quadrants. Data shown are from one of three independent experiments.
(B) The concentrations of anti-dsDNA IgG in Lat22/2Latm/m, Latm/m, Lat22/2, and Lat2+/+ mice at 4, 6, 8, and 10 weeks old. Each circle represents
the concentration of anti-dsDNA IgG from each mouse measured by ELISA.Dysfunctional T Cells Caused the Autoimmunity
in Lat22/2 Mice
LAB is expressed in B cells, mast cells, NK cells, and ac-
tivated T cells as demonstrated here. To determine a
specific role of LAB in each cell type, we generated con-
ditional knockout mice in which the Lat2 gene could be
deleted upon expression of the Cre recombinase. We
used two different recombinase systems to remove the
neomycin-resistant gene and two critical exons. These
two exons to be deleted encode the transmembrane
domain and the palmitoylation sites. In the targeting con-
struct, two FLP recombinase recognition sequences
(FRT) flanked the PGK-Neo DNA fragment. One LoxP
site was placed at the 50 end of FRT and the other one
was placed at the 30 end of the exons to be deleted.
This construct was used to transfect ES (embryonic
stem) cells. Chimeric mice were produced with positive
ES cells and were crossed with transgenic mice ex-
pressing FLP to remove the Neo gene. After deletion of
the PGK-Neo fragment, these mice were then crossed
with LckCre transgenic mice to specifically delete the
Lat2 gene in T cells. As shown in Figure 7A, cells from
LckCre+Lat2f/f mice expressed a similar amount of LAB
protein compared with B cells from Lat2+/+ mice. To de-
termine whether the Lat2 gene was deleted in T cells
from LckCre+Lat2f/f mice, we activated T cells fromLat2+/+, LckCre+Lat2f/f, and Lat22/2 mice with anti-CD3
and expanded these cells in IL-2 medium. Activated
T cells were purified and lysed. Lysates were subjected
to anti-LAB immunoprecipitation. As shown in Figure 7A,
LAB protein was absent in activated T cells from
LckCre+Lat2f/f and Lat22/2 mice while it was expressed
in T cells from Lat2+/+ mice. These data indicated that
the Lat2 gene was successfully deleted in T cells from
LckCre+Lat2f/f mice.
We next examined whether LckCre+Lat2f/f mice also
developed an autoimmune syndrome like Lat22/2
mice. Indeed, 6-month-old LckCre+Lat2f/f mice had
splenomegaly compared with the age-matched Lat2+/+
mice (data not shown). Analysis of activation markers
of T cells, CD25, CD69, CD44, CD62L, and CD45RB
showed that there were more activated CD4+ T cells in
LckCre+Lat2f/f mice like in Lat22/2 mice (Figure 7B).
However, different from Lat22/2 mice, CD8+ T cells in
LckCre+Lat2f/f mice had a similar expression of these
markers (data not shown). Similar to T cells in aged
Lat22/2mice, T cells from aged LckCre+Lat2f/f mice pro-
duced more IL-2, IL-10, and IFN-g compared with those
from Lat2+/+ mice (Figure 7C). In addition, LckCre+Lat2f/f
mice also had high concentrations of dsDNA antibodies
(Figure 7D). These data suggested that abnormal T cells
cause autoimmunity in Lat22/2 mice.
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(A) Deletion of Lat2 in T cells. Splenocytes from LckCre+Lat2f/f, Lat22/2, and Lat2+/+ mice were activated via CD3 and expanded in the medium
with IL-2. Cells were lysed and subjected to anti-LAB immunoprecipitation followed by an anti-LAB immunoblot. T cell lysates were also blotted
with anti-LAT. Data shown are from one of three independent experiments.
(B) Splenocytes from 6-month-old LckCre+Lat2f/f and Lat2+/+ mice were stained with anti-CD4, CD8, and different T cell activation markers as
indicated in the figure. The shadowed histogram represents CD4+ T cells from Lat2+/+ mice. The dark-lined histogram represents CD4+ T cells
from LckCre+Lat2f/f mice. The numbers indicate the percentages of activated cells from LckCre+Lat2f/f (top) and Lat2+/+ (bottom) mice. The figure
shown is representative of five mice for each genotype.
(C) Cytokine production in CD4+ T cells from 6-month-old LckCre+Lat2f/f and Lat2+/+ mice. The shadowed histogram represents Lat2+/+ T
cells, and the dark-lined histogram represents LckCre+Lat2f/f T cells. The numbers indicate the percentages of cytokine-producing cells for
LckCre+Lat2f/f (top) and Lat2+/+ (bottom) mice. The figure shown is representative of three experiments.
(D) The presence of dsDNA antibodies in the sera from LckCre+Lat2f/f mice. Sera from 6-month-old LckCre+Lat2f/f and Lat2+/+ mice were diluted
and used in ELISA for detection of dsDNA antibody. Data show mean of OD450 in each dilution of sera from five different mice in each group. Bars
indicate mean 6 SD.Discussion
In this report, we showed that a transmembrane adaptor
protein, LAB, could negatively regulate T cell activation,
likely by antagonizing LAT function. Previous studies
show that LAB is not expressed in naive T cells. LAB de-
ficiency was therefore not expected to have an effect on
T cell function. However, in aged Lat22/2 mice, T cells
were hyperactivated and produced more cytokines,
leading to development of a spontaneous autoimmune
syndrome. The autoimmunity in these mice is most likely
a consequence of abnormal T cell function, as indicated
by the fact that the conditional knockout mice with the
Lat2 gene deleted in T cells showed similar phenotypes
to those of Lat22/2 mice. Although our data suggested
that deficiency of LAB in T cells caused the autoimmune
syndrome in Lat22/2 mice, we could not totally exclude
the possibility that deficiency of LAB in B cells or other
cell types also contribute to the autoimmunity in Lat22/2
mice. LAB was more abundant in B cells (Figures 3B and
3D) or macrophages (data not shown) than in activated
T cells. In the absence of LAB, B cells or macrophages
could also be functionally abnormal. This possibilitywill be tested in the future via LAB conditional knockouts
in each of these cell types.
Analysis of splenocytes from aged LAB-deficient mice
showed that splenomegaly was not due to just expan-
sion of T cells. The percentages of T and B cells were
similar to those in age-matched wild-type mice, indicat-
ing that both T and B cell populations were expanded
proportionally in Lat22/2 mice. It is possible that cyto-
kines produced by hyperactivated T cells could promote
expansion of B cells. Lat22/2 B cells could also undergo
faster expansion than Lat2+/+ B cells without any influ-
ence from Lat22/2 T cells.
LAB is not expressed in naive T cells. Why did LAB de-
ficiency cause abnormal T cell function? Our data indi-
cated that T cell activation induced upregulation of
LAB, which might function to turn off T cell activation.
Our in vitro data indicated that in activated T cells with-
out LAB protein, TCR-mediated signaling events, such
as LAT phosphorylation, Akt activation, and calcium
mobilization, were enhanced. In contrast, overexpres-
sion of LAB in T cells suppressed TCR-mediated signal-
ing. A negative role for LAB in T cells was supported by
our in vivo experiments. LAB deficiency aggravated the
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expansion of CD4+ T cells in the LatY136F mice. In
addition, we have also examined NP-specific antibody
response in LAB-deficient mice. While there were no dif-
ferences in T-independent antibody response or T-
dependent primary antibody response between Lat22/2
and Lat2+/+ mice as previously reported (Wang et al.,
2005), T-dependent secondary response was substan-
tially enhanced in Lat22/2 mice (data not shown). Fur-
thermore, T-dependent, NP-specific secondary anti-
body response was also enhanced in LckCre+Lat2f/f
mice (data not shown). These data further supported
our conclusion that LAB negatively regulates T cell
function.
TCR-mediated signaling was enhanced in Lat22/2
T cells. In the absence of LAB, more LAT moved to lipid
rafts, leading to enhanced LAT phosphorylation and cal-
cium mobilization. How LAB deficiency affects LAT lo-
calization to lipid rafts is not clear. While the importance
of lipid rafts in TCR-mediated signaling is still a topic of
debate, we believe that more LAT localized to lipid rafts
might also be a reflection of changes in LAT palmitoyla-
tion status, because only palmitoylated LAT could local-
ize to rafts. It is likely that LAT and LAB might be palmi-
toylated by the same enzyme(s). When LAB is missing,
more LAT gets palmitoylated. We have attempted to ex-
amine the palmitoylation status of LAT in activated WT
and Lat22/2 T cells by metabolic labeling with [3H]palmi-
tate, and we did not observe substantial differences in
LAT palmitoylation. It is possible that in vitro labeling
with [3H]palmitate for 3 hr is not sensitive enough to de-
tect the differences in palmitoylation. Because LAB tyro-
sine phosphorylation was much weaker than LAT phos-
phorylation upon engagement of the TCR in activated T
cells, it is less likely that LAB competes for binding pro-
teins that LAT normally binds, such as Grb2 and Gads.
While competing for localization to lipid rafts or palmi-
toylation could be the mechanism by which LAB nega-
tively regulates T cell activation, it is also possible that
LAB might be actively involved in regulation of LAT func-
tion, for example by recruiting proteins to lipid rafts to
target LAT for degradation or phosphatases to dephos-
phorylate LAT.
The immune system uses peripheral tolerance to pre-
vent self-reactive lymphocytes from attacking host tis-
sues. Several mechanisms that contribute to peripheral
tolerance include activation-induced cell death, sup-
pression by regulatory T cells, and T cell anergy (Heiss-
meyer and Rao, 2004). Anergy induction leads to upre-
gulation of several E3 ubiquitin ligases (Heissmeyer
et al., 2004) or reduced LAT palmitoylation (Hundt
et al., 2006). Our data indicated that the autoimmune
syndrome in Lat22/2 mice was not due to reduced acti-
vation-induced cell death or abnormal Treg cell devel-
opment and function. In addition, negative selection
was also normal in male Lat22/2 HY transgenic mice
(data not shown). In Lat22/2 T cells, more LAT was pres-
ent in lipid rafts, and TCR-mediated signaling was en-
hanced. Because LAT-mediated signaling is decreased
in anergic T cells, it is possible that LAB deficiency en-
hances LAT function, leading to a reduction in T cell
anergy.
Both Lat22/2 and the transgenic mice overexpressing
LAB in Lat2/2 T cells develop a spontaneous autoim-mune syndrome (Janssen et al., 2004). Although this
seems puzzling, the mechanisms for causing the syn-
drome are likely different in these mice. The phenotype
of transgenic mice overexpressing LAB were very simi-
lar to that of the LatY136F mice (Aguado et al., 2002;
Sommers et al., 2002). The autoimmune conditions in
LatY136F mice and the LAB transgenic mice are more
severe than in Lat22/2 mice. Studies with the LatY136F
mice show that negative selection and development of
Treg cells are affected in the absence of the LAT-
PLCg1 interaction (Koonpaew et al., 2006; Sommers
et al., 2005). However, in Lat22/2 mice, negative selec-
tion and development of Treg cells were normal likely
due to the presence of WT LAT. This is expected be-
cause LAB expression is very low or absent in thymo-
cytes and naive T cells. Since TCR signaling was en-
hanced in activated Lat22/2 T cells, LAB deficiency
might cause prolonged T cell activation and gradual ac-
cumulation of autoreactive T cells in mice, leading to de-
velopment of autoimmunity. In conclusion, we provide
evidence that LAB deficiency leads to enhanced TCR
signaling and T cell activation and development of auto-
immunity. Our findings here, together with previously
published studies, demonstrate a critical role for trans-
membrane adaptor proteins in integrating and fine-
tuning signaling downstream of the TCR.
Experimental Procedures
Mice
Lat22/2 and Lat2Tg mice have been described previously (Janssen
et al., 2004; Zhu et al., 2004). Lat22/2 mice have been crossed onto
C57Bl/6 background for at least 10 generations. The LatY136F mice
(Latm/m) were kindly provided by L. Samelson. The Lat2 conditional
knockout construct was made with a 2835 bp XbaI and BamHI frag-
ment from the Lat2 BAC clone as the short arm, a 978 bp BamHI and
EcoRV fragment as the fragment to be deleted upon expression of
the Cre recombinase, and a 6943 bp BamHI and XbaI fragment as
the long arm. After transfection of ES cells with the targeting con-
struct, positive clones were identified by PCR. Positive ES cell clones
were injected into blastocysts to generate chimeric mice. All mice
were used in accordance with the National Institutes of Health guide-
lines. The experiments described in this study were reviewed and ap-
proved by the Duke University Institutional Animal Care Committee.
Mice were housed in specific pathogen-free conditions.
LAB Expression by Real-Time PCR and Immunoblot
Total RNAs from cells sorted by FACS or purified by MACS were ex-
tracted with the Trizol reagent. cDNAs were synthesized with Super-
Script reverse transcriptase (Invitrogen) with oligo-dT as a primer.
Quantitation of the LAB RNA was performed by real-time PCR with
SYBR Green Supermix (Bio-Rad). The following primers were used
to amplify LAB: 50-CCCTCACCCTCAGCCTTA-30 and 50-AGCAGCA
ATAATCCCGACA-30. Real-time PCR was performed in triplicates.
The amount of LAB RNA was normalized relative to the b-actin
RNA. For detection of the LAB protein, cells were lysed in RIPA lysis
buffer. Postnuclear lysates were immunoprecipitated with rabbit
anti-LAB sera. For immunoblotting, samples were separated by
SDS-PAGE and transferred onto nitrocellulose membranes. After in-
cubation with primary antibodies, membranes were probed with ei-
ther goat anti-mouse or anti-rabbit Ig conjugated with Alexa Fluor
680 (Molecular Probes) or IRDye 800 (Rockland). Membranes were
then visualized and quantified with an infrared fluorescence imaging
system (LI-COR Bioscience).
FACS Analysis and Detection of Autoantibodies
Single-cell suspensions were prepared from mouse spleens and
were stained with the following antibodies: FITC-conjugated anti-
CD4, PE-Cy5-conjugated anti-CD8 and CD44, and phycoerythrin
(PE)-conjugated anti-CD25, CD69, CD62L, CD45RB, and B220
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767(eBioscience). For intracellular staining of cytokines, splenocytes
were stimulated with 40 ng/ml of PMA and 500 ng/ml of ionomycin
for 1 hr. After addition of Golgi-Stop, cells were allowed to be stim-
ulated for additional 3–4 hr. The antibodies used for staining of intra-
cellular cytokines were the following: FITC-anti-IFN-g, IL-10, and
PE-anti-IL-2 (eBioscience). Intracellular staining of Foxp3 and de-
tection of autoantibodies were done as we did previously (Koon-
paew et al., 2006). For CFSE labeling, purified T cells were incubated
with 5 mM CFSE in 5% FBS in PBS for 5 min at 37C and were then
stimulated with different concentrations of anti-CD3 in the presence
of 0.5 mg/ml of anti-CD28 for 2 days before FACS analysis.
Proliferation and Cytokine Production of Activated T Cells
To prepare activated T cells, splenocytes were cultured in CD3 anti-
body (2C11)-coated plates in the presence of murine IL-2 (10 ng/ml)
for 2 days and then were moved into new plates to expand for 3 more
days in the presence of IL-2. Activated CD4+ or CD8+ cells were pu-
rified by positive selection with MACS beads (Miltenyi Biotec).
For assay of T cell proliferation, purified CD4+ and CD8+ T cells
(105 cells/well in 96-well plates) or purified activated CD8+ T cells
(2 3 104 cells/well in 96-well plates) were incubated either with me-
dium alone, with anti-CD3 (0.05–5 mg/ml) and anti-CD28 (0.5 mg/ml),
or with PMA (40 ng/ml) plus ionomycin (500 ng/ml) for 24 hr. Cells
were stimulated in triplicates followed by a 6 hr pulse with 1 mCi
[3H]thymidine per well. Incorporation of [3H]thymidine was mea-
sured with a liquid scintillation luminescence counter (Perkin Elmer).
For cytokine production, purified activated CD8+ T cells were rested
for 6 hr before stimulation with anti-CD3 (5 mg/ml) and anti-CD28 (0.5
mg/ml), or PMA and ionomycin for 4 hr. The concentrations of cyto-
kines secreted into the culture supernatants were determined with
the Bio-Plex mouse cytokine Th1/Th2 kit according to the manufac-
turer’s protocol (Bio-Rad).
MAPK Activation and Calcium Mobilization
Purified activated T cells were rested in medium without IL-2 for 6 hr
before being stimulated with anti-CD3 (5 mg/ml) and anti-CD4 (1 mg/
ml) or with anti-CD3 (5 mg/ml) and anti-CD8 (1 mg/ml) for 0, 1.5, and 5
min. Cells were lysed with RIPA buffer. Protein samples were re-
solved on the SDS-PAGE and blotted with anti-phospho-PLC-g1,
PLC-g1, phospho-p44/42 Erk, Erk2, phospho-Akt (Ser473), pan-
Akt (Cell Signaling), and other antibodies as indicated in each figure.
For calcium mobilization in activated T cells, activated spleno-
cytes were first loaded with indo-1 in Ca2+ loading buffer (13
HBSS with 10 mM HEPES and 1% FBS) for 30 min and then stained
with PE-CD4 or PE-CD8. Ca2+ flux was assayed by monitoring the
fluorescence emission ratio at 405/495 nm with FACS. Calcium
flux was initiated by addition of anti-CD3-biotin (5 mg/ml) and anti-
CD4-biotin (1 mg/ml) or anti-CD8 biotin (1 mg/ml) followed by cross-
linking with streptavidin (25 mg/ml).
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